Skip to content

Clinical trials

Completed Cognitive Dysfunction trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Status: Completed Country / region: Germany Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20082
20092
20103
20112
20123
20133
20145
20153
20162
20174
20184
20194
20202
20211
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Charite University, Berlin, Germany7
University Hospital Tuebingen3
Avraham Pharmaceuticals Ltd2
German Center for Neurodegenerative Diseases (DZNE)2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
RWTH Aachen University2
University of Konstanz2
Universität des Saarlandes2
Universitätsklinikum Hamburg-Eppendorf2
Daacro1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction45
Dementia13
Alzheimer Disease8
Mental Disorders4
Nervous System Diseases4
Memory Disorders3
Neurocognitive Disorders3
Neurodegenerative Diseases3
Brain Diseases2
Central Nervous System Diseases2

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.